Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2-Reference-Cited by-同舟云学术

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

Published:2012-08-20 Issue:36 Volume:109 Page:14476-14481
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Greulich H.,Kaplan B.,Mertins P.,Chen T.-H.,Tanaka K. E.,Yun C.-H.,Zhang X.,Lee S.-H.,Cho J.,Ambrogio L.,Liao R.,Imielinski M.,Banerji S.,Berger A. H.,Lawrence M. S.,Zhang J.,Pho N. H.,Walker S. R.,Winckler W.,Getz G.,Frank D.,Hahn W. C.,Eck M. J.,Mani D. R.,Jaffe J. D.,Carr S. A.,Wong K.-K.,Meyerson M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference47 articles.

1. Cancer statistics, 2011

2. Exploiting the balance between life and death: Targeted cancer therapy and “oncogenic shock”

3. Addiction to Oncogenes--the Achilles Heal of Cancer

4. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

5. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-targeted therapies beyond breast cancer — an update;Nature Reviews Clinical Oncology;2024-07-22

2. Clinical and structural insights into the rare but oncogenic HER2-activating missense mutations in non-small cell lung cancer: a retrospective ATLAS cohort study;Discover Oncology;2024-07-16

3. Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data;ESMO Real World Data and Digital Oncology;2024-06

4. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer;JCO Precision Oncology;2024-05

5. Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants;Nature Communications;2024-03-28